Auravax Therapeutics, Inc.

Houston, TX

UEI
PAN3ZK2YLAL2
CAGE
969E2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
807 Wendel St, Houston, TX 77009, USA
Website
auravax.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $749,999

Contract awards

Quick answers

Is Auravax Therapeutics, Inc. registered in SAM.gov?

Yes. Auravax Therapeutics, Inc.'s SAM.gov registration is active through January 21, 2027.

What is Auravax Therapeutics, Inc.'s CAGE code?

Auravax Therapeutics, Inc.'s CAGE code is 969E2, and its Unique Entity ID (UEI) is PAN3ZK2YLAL2.

How much has Auravax Therapeutics, Inc. received in federal contracts?

Federal contracts obligated $749,999 to Auravax Therapeutics, Inc. in fiscal years 2023 through 2027.

What is Auravax Therapeutics, Inc.'s most recent federal award?

Auravax Therapeutics, Inc.'s most recent federal contract award is The overall objective of this contract is to assess the ability of AURAVAX therapeutics? (AURAVAX) novel mucosal… (75A50124C00054), from Office of the Assistant Secretary for Preparedness and Response, on September 23, 2024.

On GovTribe

See Auravax Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe